Clinical case discussion: breast cancer in young women (part 3)
E-session 590000
The cases will focus on:
- Locally advanced therapy
- Mutated patients
- Chemotherapy indications in HR+ patients when gene-expression profile is not available
Expert
/attachment.e-eso.net%2F48%2F2020051411345688.jpg)
Medical Oncologist
Champalimaud Clinical Center
Lisbon, Portugal
Champalimaud Clinical Center
Lisbon, Portugal
Expert
/attachment.e-eso.net%2F48%2F2021052110303579.jpg)
Riviera-Chablais Hospital
Rennaz, Switzerland
Rennaz, Switzerland
Expert
/attachment.e-eso.net%2F48%2F2021032507560039.jpg)
Hadassah University Hospital - Sharett Institute of Oncology
Jerusalem, Israel
Jerusalem, Israel
Expert
/attachment.e-eso.net%2F48%2F2021050609140006.jpg)
Dana-Farber Cancer Institute
Boston, USA
Boston, USA
Presenter
/attachment.e-eso.net%2F48%2F2021100410144560.jpg)
AC Camargo Cancer Center
Sao Paulo, Brazil
Sao Paulo, Brazil
Presenter
/attachment.e-eso.net%2F48%2F2021092807322167.jpg)
Sanatorio Juan XXIII
General Roca, Rio Negro, Argentina
General Roca, Rio Negro, Argentina
Presenter
/attachment.e-eso.net%2F48%2F2021092909341501.jpg)
Centro Universitario Contra el Cáncer UANL
Monterrey, Mexico
Monterrey, Mexico
This e-Session is part of the following pathway(s):
18
Oct 2021
